The drug erythropoietin, often called EPO, is banned from sports because it is believed to enhance an athlete's performance and give people who use it an unfair advantage over unenhanced competitors. However a new systemic review of existing research, published in the British Journal of Clinical Pharmacology, reveals that there is no scientific evidence that it does enhance performance, but there is evidence that using it in sport could place a user's health and life at risk.
Professional cycling is a popular sport, but over the last decades the sport's image has been tainted by high-profile doping cases. EPO, a blood-cell stimulating hormone, has recently made headlines, with the United States of America's anti-doping agency (USADA) claiming that it was used by record seven-time Tour de France winner Lance Armstrong.
"Athletes and their medical staff may believe EPO enhances performance, but there is no evidence that anyone performed good experiments to check if EPO would actually improve performance in elite cyclists," says lead researcher Professor Adam Cohen, who works at the Centre for Human Drug Research in Leiden, The Netherlands.
On the other hand, the possible harm is well documented. EPO thickens a person's blood, which can lead to an increased risk of clots. These clots obstruct blood flow to areas of tissue, and so oxygen doesn't get to the cells and they die, damaging the organ. If the organ is your heart or your brain this can be particularly dangerous, potentially resulting in heart attack or stroke.
Normally EPO is used in medicine to treat people with anaemia, where its effect on each patient is carefully monitored. Professor Cohen points out that researchers work hard to prevent patients taking drugs that don't work or have dangerous side-effects. "So why should the standards be different for the same drugs used in athletes?" he asks.
"Although doping is forbidden, the pressure to win in sport is so great that some athletes seem to be willing to try any way of getting ahead of their competitors. When elite athletes and their coaches discover that there is no evidence of benefit and clear risk of harm, I hope many may reconsider trying to cheat. Education may work where attempts at enforcement have failed," says Cohen.
"I believe there is a clear need for high-quality research to investigate the effects of supposedly enhancing drugs in sport. If, as is expected, many substances in current use are found to be ineffective it will help keep our athletes safe and improve confidence in sporting results," says Cohen.
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Think of all the adults you know. Think of your parents and grandparents. Think of the teachers you had at school, your doctors and dentists, the people who collect your rubbish, and the actors you see on TV. All of these people probably have little mites crawling, eating, sleeping, and having sex on their faces.
A trial vaccine against Ebola could be tested on healthy volunteers in the UK in September, says an international health consortium.
The ALS Association has raised more than $94 million in recent weeks via its online ice bucket challenge — compared with $2.7 million this time last year. Now what?
Implant attached to bone in pioneering technique that helps prevent infection and discomfort
A new method for removing allergens from peanuts means help could soon be on the way for the roughly 2.8 million Americans with a potentially life-threatening allergy to the popular food, the U.S. Department of Agriculture said on Tuesday.
Survey finds many social media users hesitate to express opinions unless they know their followers will agree with them
Ebola has a nasty reputation for damaging the body, especially its blood vessels. But when you look at the nitty-gritty details of what happens after a person is infected, a surprising fact surfaces.
You think bringing a new toothbrush to market is easy? The seven-year saga of two dental entrepreneurs struggling to bring their patented brush to consumers suggests otherwise.
Scholars have long tried to understand how culture affects communities. New research argues that the parking behavior of drivers may tell us something about the economic productivity of nations.
Research suggests that unfamiliar flu strains cause immune system to release broadly effective antibodies